Список литературы

150. Tan N.Y., Mohsin Y., Hodge D.O. et al. Catheter ablation for atrial arrhythmias in patients with cardiac amyloidosis // J. Cardiovasc. Electrophysiol. 2016. Vol. 27, N 10. P. 1167-1173.

151. Tebbe U., Bramlage K., John F. et al. Endomyocardial biopsy in patients with cardiomyopathy of unknown origin: does specialized center experience apply to a tertiary care hospital? // BMC Res. Notes. 2016. Vol. 9, N 1. P. 459.

152. Thebault C., Ollivier R., Leurent G. et al. Mitochondriopathy: a rare aetiology of restrictive cardiomyopathy // Eur. J. Echocardiogr. 2008. Vol. 9, N 6. P. 840-845.

153. Tran Ba S.N., Lidove O., Dorent R. et al. [Combined heart and kidney transplantation in Fabry’s disease: long-term outcomes in two patients] // Rev. Med. Interne. 2017. Vol. 38, N 2. P. 137-142.

154. Treibel T.A., Fontana M., Gilbertson J.A. et al. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement // Circ. Cardiovasc. Imaging. 2016. Vol. 9, N 8. pii: e005066. Longhi S., Lorenzini M., Gagliardi C. et al. Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis // JACC Cardiovasc. Imaging. 2016. Vol. 9, N 3. P. 325-327.

155. Troncone L., Luciani M., Coggins M. et al. Aβ amyloid pathology affects the hearts of patients with Alzheimer’s disease: mind the heart // J. Am. Coll. Cardiol. 2016. Vol. 68, N 22. P. 2395-2407.

156. Tsou A.Y., Paulsen E.K., Lagedrost S.J. et al. Mortality in Friedreich ataxia // J. Neurol. Sci. 2011. Vol. 307, N 1-2. P. 46-49.

157. van der Velden J., Ho C.Y., Tardiff J.C. et al. Research priorities in sarcomeric cardiomyopathies // Cardiovasc. Res. 2015. Vol. 105, N 4. P. 449-456.

158. Van Driest S.L., Jaeger M.A., Ommen S.R. et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy // J. Am. Coll. Cardiol. 2004. Vol. 44, N 3. P. 602-610.

159. Velazquez-Ceceña J.L., Lubell D.L., Nagajothi N. et al. Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease // Tex. Heart Inst. J. 2009. Vol. 36, N 1. P. 50-54.

160. Weidemann F., Störk S., Liu D. et al. Cardiomyopathy of Friedreich ataxia // J. Neurochem. 2013. Vol. 126, suppl. 1. P. 88-93.

161. Werner R.A., Rudelius M., Thurner A. et al. Cardiac manifestation of acute lymphoblastic leukemia // Clin. Nucl. Med. 2016. Vol. 41, N 7. P. 570-571.

162. Willott R.H., Gomes A.V., Chang A.N. et al. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? // J. Mol. Cell. Cardiol. 2010. Vol. 48, N 5. P. 882-892.

163. Wilmshurst P.T., Katritsis D. Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes // Heart. 1996. Vol. 75, N 1. P. 94-97.

164. Wiseman D.H., Mercer J., Tylee K. et al. Management of mucopolysaccharidosis type IH (Hurler’s syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience // J. Inherit. Metab. Dis. 2013. Vol. 36, N 2. P. 263-270.

165. Xu Q., Dewey S., Nguyen S., Gomes A.V. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes // J. Mol. Cell. Cardiol. 2010. Vol. 48, N 5. P. 899-909.

166. Yoon G., Soman T., Wilson J. et al. Cardiac transplantation in Friedreich ataxia // J. Child Neurol. 2012. Vol. 27, N 9. P. 1193-1196.

167. Yoshita M., Ishida C., Yanase D., Yamada M. Immunoglobulin light-chain (AL) amyloidosis with myasthenic symptoms and echocardiographic features of dilated cardiomyopathy // Intern. Med. 2006. Vol. 45, N 3. P. 159-162.

168. Zamorano J.L., Lancellotti P., Rodriguez Muñoz D. et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) // Eur. Heart J. 2016. Vol. 37, N 36. P. 2768-2801.

169. Zizek D., Cvijić M., Zupan I. Cardiac resynchronization therapy in a patient with amyloid cardiomyopathy // Acta Cardiol. 2013. Vol. 68, N 3. P. 335-337.

170. Zorzi A., Calore C., Vio R. et al. Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete's heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria // Br. J. Sports Med. 2017 Jul 12. pii: bjsports-2016-097438.

1. Новиков Ю.И., Али Шах Миан Санд, Стулова М.А. О связи гипертрофической кардиомиопатии с вирусными и идиопатическими миоперикардитами // Клин. мед. 2000. № 9. С. 15-21.

2. Adachi S., Amano J., Ito H. et al. Porphyria cutanea tarda with constrictive pericarditis in a family // Jpn. Heart J. 1997. Vol. 38, N 5. P. 749-753.

3. Adler Y., Charron P., Imazio M. et al.; European Society of Cardiology (ESC). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS) // Eur. Heart J. 2015. Vol. 36, N 42. P. 2921-2964.

4. Alter P., Figiel J.H., Rupp T.P. et al. MR, CT, and PET imaging in pericardial disease // Heart Fail. Rev. 2013. Vol. 18, N 3. P. 289-306.

5. Brucato A., Brambilla G., Moreo A. et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis // Am. J. Cardiol. 2006. Vol. 98, N 2. P. 267-271.

6. Bruyn G.A., De Koning J., Reijsoo F.J. et al. Lyme pericarditis leading to tamponade // Br. J. Rheumatol. 1994. Vol. 33, N 9. P. 862-866.

7. Clinckaert C., Bidgoli S., Verbeet T. et al. Peroperative cardiogenic shock suggesting acute coronary syndrome as initial manifestation of Lyme carditis // J. Clin. Anesth. 2016. Vol. 35. P. 430-433.

8. DeLine J.M., Cable D.G. Clustering of recurrent pericarditis with effusion and constriction in a family // Mayo Clin. Proc. 2002. Vol. 77, N 1. P. 39-43.

9. Dong A., Dong H., Wang Y. et al. (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study // Clin. Nucl. Med. 2013. Vol. 38, N 4. P. e160-e165.

10. Dyrda K., Piers S.R., van Huls van Taxis C.F. et al. Influence of steroid therapy on the incidence of pericarditis and atrial fibrillation after percutaneous epicardial mapping and ablation for ventricular tachycardia // Circ. Arrhythm. Electrophysiol. 2014. Vol. 7, N 4. P. 671-676.

11. Imazio M., Belli R., Brucato A. et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial // Lancet. 2014. Vol. 383, N 9936. P. 2232-2237.

12. Imazio M., Bobbio M., Cecchi E. et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial // Circulation. 2005. Vol. 112, N 13. P. 2012-2016.

13. Imazio M., Brucato A., Cumetti D. et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation // Circulation. 2008. Vol. 118, N 6. P. 667-671.

14. Kostić T., Momčilović S., Perišić Z.D. et al. Manifestations of Lyme carditis // Int. J. Cardiol. 2017. Vol. 232. P. 24-32.

15. Lazaros G., Imazio M., Brucato A. et al. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidence // J. Cardiovasc. Med. (Hagerstown). 2016. Vol. 17, N 4. P. 256-262.

16. Levy Y., Shovman O., Granit C. et al. Pericarditis following permanent pacemaker insertion // Isr. Med. Assoc. J. 2004. Vol. 6, N 10. P. 599-602.

17. Maisch B., Pankuweit S. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives // Heart Fail. Rev. 2013. Vol. 18, N 6. P. 761-795.

18. Maisch B., Rupp H., Ristic A, Pankuweit S. Pericardioscopy and epi- and pericardial biopsy - a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy // Heart Fail Rev. 2013. Vol. 18, N 3. P. 317-328.

19. Maisch B., Ristić A.D., Seferović P.M., Tsang T.S. Interventional Pericardiology. Pericardiocentesis, Pericardioscopy, Pericardial Biopsy, Balloon Pericardiotomy and Intrapericardial Therapy. Springer, 2011. 207 p.

20. Maisch B.; European Society of Cardiology. [Progress or regress or both? ESC Guidelines on pericardial diseases 2015] // Herz. 2015. Vol. 40, N 8. P. 1061-1069.